Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cycling without CDK2?

Jonathan E Grim1, Bruce E Clurman

  • 1Divisions of Clinical Research and Human Biology, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109, USA.

Trends in Cell Biology
|July 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional states define dependencies and therapeutic vulnerabilities in head and neck cancer.

NPJ precision oncology·2026
Same author

Subtype-Specific Dependencies and Drug Vulnerabilities Enable Precision Therapeutics in Head and Neck Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations.

eLife·2022
Same author

Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor.

Science advances·2022
Same author

Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12.

Nature communications·2021
Same author

FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition.

Proceedings of the National Academy of Sciences of the United States of America·2020

Cyclin-dependent kinase 2 (CDK2) is crucial for cell cycle regulation. However, some cancer cells can proliferate without CDK2, challenging its essential role and therapeutic potential.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinase 2 (CDK2) plays a key role in regulating the mammalian cell cycle.
  • Dysregulation of CDK2 pathways is common in cancer, making it a focus for therapeutic strategies.

Purpose of the Study:

  • To investigate the essentiality of CDK2 in cancer cell proliferation.
  • To evaluate the suitability of CDK2 as a cancer therapeutic target.

Main Methods:

  • Analysis of cancer cell lines with varying CDK2 activity.
  • Assessment of cell proliferation rates in the absence of functional CDK2.

Main Results:

  • Demonstrated that certain cancer cells can proliferate effectively despite lacking CDK2 activity.

Related Experiment Videos

  • Highlighted the non-essential nature of CDK2 for the survival of some cancer types.

    • Conclusions:

    • The findings question the universal requirement of CDK2 for cell-cycle control in all cancer cells.
    • CDK2 may not be a universally effective therapeutic target for all cancers.